Response to “CYP2C9 Polymorphism is Not a Major Determinant...

Response to “CYP2C9 Polymorphism is Not a Major Determinant of Bosentan Exposure in Healthy Volunteers”

Markova, S M, Schwartz, J B, Kroetz, D L
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
95
Language:
english
Journal:
Clinical Pharmacology & Therapeutics
DOI:
10.1038/clpt.2013.239
Date:
March, 2014
File:
PDF, 138 KB
english, 2014
Conversion to is in progress
Conversion to is failed